文献速递瓣膜外科

主动脉瓣置换术后早期肌酐小幅度升高与远期生存、心衰及慢性肾脏病:全国注册研究

Early Creatinine Changes After Aortic Valve Replacement and Late Survival, Heart Failure, and Chronic Kidney Disease in a National Registry.
PubMed 文献 · Ann Thorac Surg · 2024-07-04

该观察性队列研究纳入2009至2022年瑞典所有接受初次外科主动脉瓣置换术(SAVR)的成人患者,共16,766例。术后血清肌酐小幅度升高(0.06 mg/dL ≤ Δserum creatinine <0.3 mg/dL)与远期慢性肾脏病和心力衰竭风险增加相关,但与长期全因死亡率无显著差异;30天死亡率风险随肌酐变化幅度增加呈阶梯式上升。

要点

  • 术后肌酐小幅度升高(未达AKI 1期)与远期慢性肾脏病和心衰风险增加相关。
  • 术后肌酐无变化组与小幅升高组13年全因死亡率无显著差异。
  • 30天死亡率风险随术后肌酐变化幅度增加呈阶梯式上升。

核心结论

  • SAVR术后血清肌酐小幅度升高与不良结局风险增加相关。
  • 当前AKI定义或可受益于纳入更可靠和特异的生物标志物联合肌酐小幅度升高来检测肾损伤。

研究设计与样本

  • 观察性队列研究,纳入2009至2022年瑞典所有接受初次SAVR的成人患者,共16,766例,采用回归标准化处理混杂。

主要发现

  • 在16,766例患者中,4,074例(24.2%)术后血清肌酐无变化,5,764例(34.3%)术后血清肌酐小幅度升高(0.06 mg/dL ≤ Δserum creatinine <0.3 mg/dL),2,753例(16.4%)符合KDIGO AKI 1期标准。
  • 平均年龄67岁,31%为女性。
  • 术后肌酐无变化组与小幅升高组13年全因死亡率无显著差异(绝对生存差异2.3% [95% CI, 0%-4.6%])。
  • 30天死亡率风险随血清肌酐变化幅度增加呈阶梯式上升。
  • 随访13年时,无变化组与小幅升高组慢性肾脏病风险有显著差异(绝对差异2.8% [95% CI, 1.0%-4.5%]),心力衰竭风险亦有显著差异(绝对差异3.5% [95% CI, 1.3%-5.7%])。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of small increases in serum creatinine after surgical aortic valve replacement (SAVR) that fail to meet the acute kidney injury stage 1 criteria is unknown. The aim of this study was to investigate prognosis after primary SAVR in patients with small increases in postoperative serum creatinine. METHODS: This observational cohort study included all adult patients who underwent primary SAVR in Sweden from 2009 to 2022. The primary outcome was all-cause mortality. Secondary outcomes were chronic kidney disease and heart failure. Regression standardization addressed confounding. RESULTS: In 16,766 patients, 4074 (24.2%) had no change in postoperative serum creatinine, 5764 (34.3%) had a small increase in postoperative serum creatinine (0.06 mg/dL ≤ Δserum creatinine <0.3 mg/dL), and 2753 (16.4%) fulfilled the Kidney Disease Improving Global Outcomes acute kidney injury stage 1 criteria. The mean age was 67 years, and 31% of patients were female. No significant difference in long-term all-cause mortality was observed in the no change group at 13 years compared with the small increase group (absolute survival difference, 2.3% [95% CI, 0%-4.6%]). A stepwise increase in the risk of 30-day mortality was observed with increasing changes in serum creatinine. At 13 years of follow-up, there was a significant difference in the risk of chronic kidney disease (absolute difference, 2.8% [95% CI, 1.0%-4.5%]) and heart failure (absolute difference, 3.5% [95% CI, 1.3%-5.7%]) between the no change and small increase groups. CONCLUSIONS: A small increase in postoperative serum creatinine after SAVR was associated with an increased risk of adverse outcomes. The acute kidney injury definition may benefit from including more reliable and specific biomarkers together with small creatinine increases to detect kidney injury.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lu R, Dismorr M, Hertzberg D, et al. Early Creatinine Changes After Aortic Valve Replacement and Late Survival, Heart Failure, and Chronic Kidney Disease in a National Registry. Ann Thorac Surg. 2024. PMID: 38971227. doi:10.1016/j.athoracsur.2024.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。